Press release
Graves Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Collaboration, and Other Developments
Explore Report at: www.psmarketresearch.com/market-analysis/graves-disease-therapeutics-pipeline-analysis
Graves disease is the result of hyperthyroidism, which basically means overproduction of thyroid gland. Hyperthyroidism cause majority of symptoms of Graves disease and it can also be associated with eyes inflammation, swelling of the tissues around the eyes and eyes bulging known as Graves ophthalmopathy. The most common symptoms of Graves disease include eye disease and skin disease. Eye disease includes redness of eyes and irritation of the eyes while skin disease includes pretibial myxedema in which a reddish lump is formed in front of the shins. The other symptoms of Graves disease are weight loss, anxiety, erectile dysfunction, change in menstrual cycles, irregular heartbeat and bulging eyes. Graves disease is an autoimmune disease in which antibodies bind to thyroid cells which results in overproduction of thyroid hormones. This results in hyperthyroidism. Graves disease is diagnosed by clinical observation and confirmed by laboratory testing which includes measuring thyroid hormone (thyroxine, or T4, and triiodothyronine, or T3) and thyroid-stimulating hormone (TSH) in patient’s blood. Also family history with thyroid or autoimmune diseases is analyzed. Some of the risk factors of Graves disease include age, family history, smoking, pregnancy and autoimmune disorders. Treatment includes anti-thyroid medications, beta blockers and surgery. It is treated using antithyroid drugs including methimazole [Tapazole] and surgery in severe cases.
Request for Table of Content at: www.psmarketresearch.com/market-analysis/graves-disease-therapeutics-pipeline-analysis/toc-sample
Some of the key companies having a pipeline of Graves disease therapeutics include AV7 Limited, Apitope International NV, Neothetics, Inc., Nova Therapeutics LLC, Novartis AG, Omeros Corp. and Rodos BioTarget GmbH.
Browse Other Related Report at: www.psmarketresearch.com/industry-report/pharmaceuticals
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
Kundan
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Graves Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Collaboration, and Other Developments here
News-ID: 540895 • Views: …
More Releases from P&S Market Research - Pharmaceuticals
Psoriasis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Paten …
The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of…
Diabetic Foot Ulcer Therapeutics Pipeline Projects Immense Growth Ahead
The study analysed that the diabetic foot ulcer pipeline comprises of approximately 27 drug candidates in different stages of development.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/diabetic-foot-ulcers-therapeutics-pipeline-analysis
Diabetic foot ulcer is a serious complication of diabetes and can be defined as the ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients. Diabetic foot ulcer is categorized into two types namely; neuropathic foot where…
Technological Advancements at Cellular and Molecular Level Strengthening the IgA …
The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis
The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the…
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
As per the findings of research, it…
More Releases for Graves
Japan Graves' disease Market Size & Growth Analysis Report, 2019-2025
Japan Graves' disease market is growing at a CAGR of around 4.7% during the forecast period. According to the WHO, around 10.1% of the country's population is suffering from diabetes, among which, the individuals suffering from type-1 diabetes are more prone to develop Grave's disease in the near future. According to IDF, around 2.2 per thousand children and adolescents aged 14 years and below are suffering from type-1 diabetes in…
Global Graves Disease Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Graves Disease Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Graves Disease Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/515950/graves-disease
Market…
US Graves' disease Market Growth, Share, Trends & Forecast to 2025
US Graves' disease market is growing at a CAGR of around 4.0% during the forecast period. The US Grave's disease market is showing significant growth due to funding for autoimmune disease researches, and the increasing prevalence of hyperthyroidism in the region. In addition, significant rise in the prevalence of autoimmune disease is also expected to propel the growth of the US Graves' disease market. According to the American Autoimmune Related…
Graves Diseases Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H1 2017, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape.
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism) . Symptoms include anxiety, weight loss, change in menstrual cycles, erectile dysfunction, bulging eyes and irregular heartbeat. Risk factors include family history, age, autoimmune disorders, smoking and pregnancy. Treatment…
Global Clinical Trials Review for Graves Diseases, H2, 2017
"The Report Graves Diseases Global Clinical Trials Review, H2, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Graves Diseases Global Clinical Trials Review, H2, 2017
Summary
GlobalDatas clinical trial report, Graves Diseases Global Clinical Trials Review, H2, 2017" provides an overview of Graves Diseases clinical trials scenario.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1335078
This report provides top line data relating to…
Graves disease Market: Positive long-term growth outlook 2017 - 2025
Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S.
In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism. Graves’ disease is the most predominant cause of hyperthyroidism in the…
